Welcome to our dedicated page for Petco Health & Wellness Company SEC filings (Ticker: WOOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Petco Health and Wellness Company, Inc. filings document the formal disclosures of a pet specialty retailer with Class A common stock listed on Nasdaq under WOOF. Its Form 8-K reports cover operating results, earnings presentations, Regulation FD updates, fiscal outlooks and material events tied to the company's retail, services and digital pet-care business.
Petco's regulatory record also includes capital-structure disclosures for credit agreement amendments, term loan refinancing, senior secured notes due 2031, subsidiary guarantees and collateral priorities. Governance filings document board leadership changes and related compensatory arrangements, while exhibit filings preserve press releases, agreements and other materials incorporated into the company's public record.
Petco Health & Wellness Company, Inc. (WOOF) – Form 4
Chief Legal Officer & Secretary Giovanni Insana reported a Code F transaction on 21 Jul 2025. Code F denotes issuer share withholding to satisfy taxes due upon vesting of restricted stock units (RSUs); no open-market trade occurred. 1,083 Class A shares were withheld at an implied $3.30 per share.
Following the settlement, Insana’s beneficial ownership stands at 469,064 Class A shares, which includes 369,727 outstanding RSUs granted under the 2021 Equity Incentive Plan. Because the transaction is administrative and represents less than 0.3 % of his total holdings, it does not materially alter the executive’s economic exposure. The filing is therefore viewed as routine and low-impact for investors.
Petco Health & Wellness Company, Inc. (WOOF) – Form 4 insider filing, 24 Jun 2025
Director Iris Yen reported the acquisition of 20,576 Class A common shares on 20 Jun 2025 at an indicated value of $2.47 per share (transaction code “A” indicates a stock grant/award, not an open-market purchase). Following the transaction, Yen’s direct ownership rose to 102,365 shares; an additional 1,983 shares are held indirectly through the Yen-Geniblazo Family Trust. The filing notes that 49,254 of the directly held shares are restricted stock units (RSUs) issued under the company’s 2021 equity plan, each convertible into one share upon vesting.
The grant increases the director’s total reported beneficial stake by roughly 25% versus pre-grant levels (derived from disclosed balances). While insider acquisitions can signal confidence, the use of RSU awards means the transaction reflects routine board compensation rather than discretionary buying. No sales were reported, and there are no accompanying derivative transactions. Overall, the filing modestly deepens insider alignment but is unlikely to be materially impactful to the company’s capital structure or trading dynamics given Petco’s ~300 million outstanding shares.